Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L22-like 1 pseudogene (RPL22L1P)
- Target
- RPL22L1P
- Molecular classification
- Other (pseudogene)
01
Overview
The ribosomal protein L22-like 1 pseudogene is a genomic sequence resembling the protein-coding RPL22L1 gene but does not encode a functional protein. Pseudogenes are non-functional remnants of genes and do not serve as direct therapeutic targets or encode biologically active molecules. The functional RPL22L1 gene encodes a paralog of ribosomal protein L22 and has been implicated in promoting cancer cell proliferation, migration, invasion, drug resistance, and epithelial-to-mesenchymal transition through MAPK/ERK activation; however, the pseudogene itself has no established biological function or disease relevance as a target.
- Other names
- Ribosomal protein L22-like 1 pseudogeneRPL22L1PRPL22L1 pseudogeneribosomal protein L22-like 1
02
Mechanism of action
None (not applicable)
03
Biological functions
None (no known independent function, as is typical for processed pseudogenes)May have limited genomic or transcriptional effects if transcribed, but no evidence for protein function
04
Disease associations
Other (not established)
Beyond the preview
Go deeper on Ribosomal protein L22-like 1 pseudogene (RPL22L1P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L22-like 1 pseudogene (RPL22L1P).